Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Project CBD

MARCH 21, 2023

The CBD she took may or may not have helped, but according to a recent survey of tinnitus patients, she wasn’t alone in trying — or at least in being interested in cannabis as a potential remedy. But many more patients were willing to try, perhaps as an indication of the intractability of chronic tinnitus.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Cannabis Law Report

JUNE 5, 2019

30 May 2019. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Google Translation. Today (30 May) at 09.30 Sick group 1.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

MassRoots

MARCH 14, 2019

The first medical cannabis product manufacturing license was just awarded in Ohio, giving patients in the program a reason to celebrate. It’ll open up the choices patients have available to them and they can purchase their medical marijuana to treat their condition,” said Executive Vice President of Grow Ohio Justin Hunt. “We

Edibles 80

Edibles Patients Tincture Programs 80

Cannabis Law Report

DECEMBER 30, 2019

This report contains a detailed summary of 2019’s federal and state legislative victories.” 2019 has been an unprecedented year for the passage of state-level marijuana law reforms. “Never before in American history has marijuana policy advanced in Congress as far or as fast in one year as 2019.

Legislation 59

Legislation Patients Access Banking 59

Veriheal

NOVEMBER 18, 2022

Texas’ medical cannabis program is in the midst of a massive spike in patient registrations. According to the Texas Department of Public Safety Chief Wayne Muller, the state has averaged a 10% month-over-month increase in medical cannabis patients over the last 18 months. Texas’ Medical Cannabis Program Sees Growth Despite Limitations.

Edibles 97

Edibles Hemp Epilepsy Programs 97

Cannabis Law Report

MARCH 29, 2019

Chad West March 27, 2019. Texas could make meaningful progress on marijuana-related bills by the end of the 2019 legislative session. Currently, only epilepsy patients may use the drug produced at three state facilities. If passed, S.B. It would also provide for licensing of dispensaries and testing facilities.

Epilepsy 45

Epilepsy Law Chronic Pain Programs 45

Veriheal

SEPTEMBER 22, 2020

The cannabis that was approved for medical use was required to have a low THC content, and patients had to register their use of the substance on the Compassionate Use Registry, arguably a violation of their privacy. The 2016 law also established more Medical Marijuana Treatment Centers, making it easier for patients to access cannabis.

Edibles 52

Edibles Patients Chronic Pain Conditions 52

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

CannaTech

JANUARY 16, 2019

Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. Of course, patients need product and product costs money.

Access 89

Access Patients Pharmaceutical Education 89

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. An estimated 250 patients a month are said to be prescribed cannabis medicines through the NHS compared to over 2,500 in the UK’s private sector. Step In Right Direction.

Data 52

Data Patients Clinical Trials Business 52

CannaTech

JUNE 30, 2019

Changes to Israeli medical cannabis regulation by the Ministry of Health’s Medical Cannabis Association, locally known as Yakar, have left vulnerable patients with reduced access and increasing cots. Although changes were intended to reduce barriers to patient access, this has not been the case. Severe epilepsy in minors.

Patients 40

Patients Oil Epilepsy Strains 40

Veriheal

MAY 11, 2023

In 2015, Texas passed the Compassionate Use Act, which allowed patients with intractable epilepsy to access low-THC cannabis oil containing no more than 0.5% In 2019, the program was expanded to include patients with other qualifying conditions, such as terminal cancer, autism, multiple sclerosis, and certain neurological disorders.

Programs 102

Programs Chronic Pain Conditions THC 102

Cannabis Law Report

JULY 7, 2022

January 2019. s patent directed to the use of cannabinoids, including cannabidiol (“CBD”), in the treatment of certain types of epilepsy. Sterne, Kessler, Goldstein & Fox P.L.L.C. Eleven of thirteen cannabis patent claims survive PTAB challenge. Insys Development Company, Inc. i] Insys Development Company, Inc. 36 (P.T.A.B.

Epilepsy 52

Epilepsy Pharmaceutical Treatment Cannabinoids 52

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m. PT (2:00 p.m.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

The Cannigma

APRIL 19, 2021

In recent years, lawmakers have eased up on a number of cannabis-derived formulations, and since 2015, people with epilepsy can obtain cannabis oil that contains less than 0.5% THC are legal for use by qualifying medical patients. Patients do not need to register with the state or pay a fee to access the medical cannabis program.

Law 84

Law Epilepsy Conditions Programs 84

The Cannigma

JUNE 1, 2021

Under the plan, some 3,000 patients in France will be treated with medical cannabis and monitored closely. The plan was initially passed in 2019 but was delayed multiple times, including because of the COVID-19 pandemic. Patients can take part if they have a medical condition which has not responded to pharmaceutical drugs.

Law 113

Law Epilepsy Programs Patients 113

Cannabis Law Report

AUGUST 19, 2019

There have been more than 7,500 approvals for medicinal cannabis in Australia since legalisation in 2016 – so why don’t we know if it is helping patients? Access to medicinal cannabis for patients was legalised in Australia in 2016, allowing doctors to request permission to prescribe from the Australian government.

Medicine 45

Medicine Patients Clinical Trials Access 45

Cannabis Law Report

MARCH 21, 2019

Georgia only allows patients diagnosed with cancer, ALS, seizures, and other serious medical conditions to legally possess CBD. In 2014, Mississippi legalized CBD for epileptic patients. THC for patients who suffer from severe epilepsy and is produced in compliance with the North Carolina Industrial Hemp Commission regulations.

State Laws 55

State Laws Law CBD Legalization 55

Canna Law Blog

OCTOBER 5, 2022

Last year, it recommended that the government allow the use of marijuana to treat “refractory epilepsy.” ” However, that didn’t go anywhere aside from Japan quietly clearing Epidiolex for clinical trials for Dravet and Lennox-Gastaut syndromes back in 2019.

Marijuana 93

Marijuana Seed-To-Sale Clinical Trials Epilepsy 93

Veriheal

SEPTEMBER 15, 2023

Though Georgia is one of the last states to officially legalize medical cannabis, the state has been gradually reforming its laws around low-THC cannabis oil for qualifying patients. In April 2019, House Bill 324 was approved, enabling in-state cultivation and the sale of low-THC oil. Want to get your Georgia medical cannabis card ?

Programs 62

Programs Legalization Oil Conditions 62

MassRoots

JANUARY 10, 2019

House Bill 136, an amendment to legalize medical marijuana, was introduced in the Kentucky Legislature on Wednesday, January 9, 2019. Lawmakers have been listening to constituents suffering from debilitating diseases, like epilepsy and cancer, who say they would like to have the option to explore how medical cannabis may ease their symptoms.

Legalization 111

Legalization Marijuana Epilepsy Legislation 111

United Patients Group

MARCH 10, 2023

He became a professor at Hebrew University in Jerusalem where he taught for more than 50 years before his death on September 1st 2019 at age 85. Thank you for ALL that you did for patients, families, science and this plant. Mechoulam also discovered that CBD and THC are two different compounds within Cannabis Sativa L. dronabinol).

Cannabinoids 97

Cannabinoids THC Sativa CBD 97

CannaTech

JUNE 30, 2019

These include changes to reduce barriers to patient access, specific licensing requirements for production, and expanding the number of access points approved of sale. The main goal of the reform is to ease bureaucratic hurdles for patients and to improve the quality and consistency of medical cannabis. Severe epilepsy in minors.

Patients 90

Patients Oil Epilepsy Strains 90

The Cannigma

MAY 15, 2023

A 2019 report from the Philippine Drug Enforcement Agency (PDEA) revealed that cannabis was the second most commonly used drug in the country, with methamphetamine being the most commonly used drug. Despite the harsh penalties, cannabis use remains prevalent in the Philippines.

Law 52

Law Chronic Pain Cultivation Recreational 52

The Joint Blog

JANUARY 31, 2021

The study is titled A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extract as complementary therapy: A case report. For the study researchers studied the effects of marijuana extracts in a fifteen-year-old who suffered from autism, anxiety, and controlled epilepsy. ml twice daily.

Epilepsy 62

Epilepsy Extraction Research and Development Clinical Trials 62

Veriheal

SEPTEMBER 27, 2021

The society launched a campaign with the hashtag #ApprovedButDenied protesting the difficulty so many patients have faced attempting to obtain medical cannabis. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? ApprovedButDenied.

Treatment 98

Treatment Patients Access Research and Development 98

Peninsula Alternative Health

MAY 15, 2019

Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. References Staff, T.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

The Cannigma

MAY 9, 2023

However, in 2019, the Jordanian government announced its plans to conduct clinical trials on the use of cannabis for medical purposes. The trials involved using cannabis to treat certain conditions such as epilepsy, chronic pain, and cancer-related symptoms, and will hopefully pave the way for medical cannabis legalization in the future.

Law 52

Law Clinical Trials Chronic Pain Recreational 52

MassRoots

AUGUST 3, 2020

Louisiana’s medical marijuana program may have been established three years ago, but patients were not granted access to medicine until August of 2019 when the first round of the product became available. Home cultivation remains illegal for the more than 4,000 registered medical marijuana patients. House Bill 819.

Programs 124

Programs Banking Marijuana Conditions 124

NORML

AUGUST 26, 2019

Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. And, 2019’s SB 1557 makes it possible for patients to get as much as 10mg of THC in each dose — the same limit as one serving size for edibles in adult-use states.

Marijuana 211

Marijuana Legalization Programs Oil 211

CannaMD

JULY 14, 2020

Polypharmacy is a growing problem where patients are prescribed multiple different medications simultaneously in order to treat a given medical condition. It’s often mistakenly believed that taking multiple medications results in better management of a patient’s symptoms, but often that’s simply not the case. WHAT IS POLYPHARMACY?

Marijuana 105

Marijuana Conditions Patients Epilepsy 105

The Cannigma

DECEMBER 24, 2022

In 2019, the country approved the cultivation of hemp for medical purposes. Doctors can prescribe cannabis-based medications, capsules, teas, ointment, and herbal products but patients can only have up to 0.75 Qualifying conditions include: Cancer AIDS Multiple sclerosis Pediatric epilepsy. Cannabis in Croatia. grams per month.

Law 59

Law Decriminalization Cultivation Recreational 59

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. September 23, 2019. What do experts say?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

JULY 16, 2021

Szaflarski, professor and director of the UAB Epilepsy Center in the Department of Neurology, according to an AL.com report. Szaflarski was also a member of a study panel that recommended medical cannabis legalization in 2019, the news outlet reported, and was a lead investigator in a UAB study on using CBD oil to treat seizure disorders.

Chronic Pain 105

Chronic Pain Epilepsy Programs Therapy 105

The Cannigma

MAY 16, 2023

Medical cannabis in Guatemala In 2019, Guatemala passed a law allowing the use of medical cannabis products containing less than 1% THC. However, the law did not legalize the cultivation of cannabis in the country, and patients must obtain their medical cannabis products from licensed importers.

Law 52

Law Treatment Epilepsy Policy 52

Cannabis Law Report

NOVEMBER 2, 2021

According to the health authority, the license to import the medicine has u n initial period of 24 months and its prescription and use will be the responsibility of the doctor who prescribes it , who will have to warn the patient that the product is based on cannabidiol.

Medicine 52

Medicine Chronic Pain Epilepsy Marijuana 52